Award
NIH Reporter #5R01HL175155-02
Defining targetable vulnerabilities in UBA1-mutated VEXAS HSCs for clonal eradication
Recipient
Not specified
Award Amount
$747,490.00
Ceiling
$747,490.00
Awarded
February 26, 2026
Identifier
5R01HL175155-02
NIH grant awarded by NHLBI for research on UBA1-mutated VEXAS hematopoietic stem cells to identify targetable vulnerabilities for clonal eradication.
Description
Research project focusing on VEXAS syndrome, somatic mutations, and hematopoietic stem cells using advanced genomic and spatial transcriptomic techniques.